Interleukin-7: a key Mediator in T Cell-driven Autoimmunity, Inflammation, and Tissue Destruction

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|18|16|2347-2356

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.18, Iss.16, 2012-06, pp. : 2347-2356

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Regulatory T Cells as Targets for Immunotherapy of Autoimmunity and Inflammation

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 4, 2008-12 ,pp. : 217-223

Bentham Science Publishers

Access to resources Recommend Favorite

Cell Death: Tipping the Balance of Autoimmunity and Tissue Repair

By  

Current Pharmaceutical Design, Vol. 14, Iss. 3, 2008-01 ,pp. : 269-277

Bentham Science Publishers

Access to resources Recommend Favorite

The Yin and Yang of Non-Neuronal α7-Nicotinic Receptors in Inflammation and Autoimmunity

By  

Current Drug Targets, Vol. 13, Iss. 5, 2012-05 ,pp. : 644-655

Bentham Science Publishers

Access to resources Recommend Favorite

EBV, autoimmunity and dual T-cell receptors

By Niller Hans Helmut   Minarovits Janos  

Future Virology, Vol. 7, Iss. 3, 2012-03 ,pp. : 217-220

Future Medicine

Access to resources Recommend Favorite

Antigen-based T-cell-targeted immunotherapy: recent developments in autoimmunity and allergy

By Stemmer C.   Guichard G.  

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 7, 1998-07 ,pp. : 819-830

Informa Healthcare

Access to resources Recommend Favorite